Relationship between Using Fibrate and Open-Angle Glaucoma in Hyperlipidemic Patients

A Population-Based Cohort Study

Bibliographic Data

ID15464765
AuthorsYung-En Tsai (0000-0003-4989-3439, Tri-Service General Hospital), Yi‐Hao Chen (0000-0002-9977-7180, Tri-Service General Hospital), Yi-Hao Chen (Department of Ophthalmology, Tri-Service General Hospital, National Defense Medical Center, Taipei 114, Taiwan), Chien‐An Sun (0000-0001-9041-0537, Fu Jen Catholic University), Chi‐Hsiang Chung (0000-0002-4576-9900, Tri-Service General Hospital), Wu‐Chien Chien (0000-0002-3286-0780, Tri-Service General Hospital, corresponding author), Ke‐Hung Chien (Tri-Service General Hospital, corresponding author), Ke-Hung Chien (Department of Ophthalmology, Tri-Service General Hospital, National Defense Medical Center, Taipei 114, Taiwan)
Year2022
Volume19
Issue4
Pages2415-2415
Publication date2022-02-19
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueInternational Journal of Environmental Research and Public Health (JOURNAL)
Journal identifiersISSN: 1661-7827 • E-ISSN: 1660-4601
PublisherMultidisciplinary Digital Publishing Institute (PUBLISHER • CH)
DOI10.3390/ijerph19042415
PMID35206602
OpenAlexW4213177569
LanguageEN
Citations received1
References cited15

Our studies showed that using fibrate for over seven years may lead to a lower risk of OAG in patients with hyperlipidemia. Nevertheless, further prospective studies that comprehensively investigate the relationship between using fibrate and OAG are needed

Cohort · Cohort study · Confidence interval · Fibrate · Hazard ratio · Incidence (geometry · Prospective cohort study · Statin · Glaucoma and retinal disorders · Medicine · Neurological disorders and treatments · Protease and Inhibitor Mechanisms · Internal Medicine

Tools

Open DOIOpen Access